# neostigmine methylsulfate

NDC: 71288-500
Generic name: neostigmine methylsulfate
Labeler / Manufacturer: Meitheal Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20210405

FDA application: ANDA212804

## Active ingredients

- NEOSTIGMINE METHYLSULFATE: .51 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71288-500"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71288-500
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5a01a429-a346-4253-8994-b58d34b57974